Virtual Reality in Cancer Patients

Overview

About this study

The primary objectives are to assess the safety and efficacy of VR in improving mental health outcomes in cancer patients. The study will monitor adverse effects, evaluate symptom changes using PROMIS – Cancer Bank v1.0 assessments (Anxiety, Depression, Fatigue), and determine VR’s therapeutic potential. Findings will inform whether VR can serve as a safe and effective psychological support tool for cancer patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • History of Cancer.
  • Age between 18 to 90 years.
  • Undergoing in-patient chemotherapy, BMT, Car-t, & out-patient chemotherapy.

Exclusion Criteria: 

  • History of bipolar disorder, major depression, bipolar disorder, anxiety disorder, PTSD, OCD, psychotic disorder, schizophrenia, personality disorder, substance use disorder other than caffeine or tobacco. History of suicidal ideation or attempt.
  • History of treatment resistant depression, psychiatric hospitalization, syncope, TIA, stroke, epilepsy, electroconvulsive therapy, Benign Positional Vertigo, Meniere’s disease.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/03/2025. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Juan Cardenas Rosales, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available
.
CLS-20590455

Mayo Clinic Footer